Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
43.8M
-
Shares change
-
+8.38M
-
Total reported value, excl. options
-
$1.4B
-
Value change
-
+$264M
-
Put/Call ratio
-
0.66
-
Number of buys
-
61
-
Number of sells
-
-37
-
Price
-
$31.88
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2016
120 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2016.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.8M shares
of 49.8M outstanding shares and own 87.93% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (10.5M shares), BAUPOST GROUP LLC/MA (9.27M shares), FMR LLC (5.57M shares), VANGUARD GROUP INC (2.96M shares), BlackRock Fund Advisors (2.22M shares), FIRST MANHATTAN CO (1.84M shares), Cormorant Asset Management, LLC (1.43M shares), BlackRock Institutional Trust Company, N.A. (1.03M shares), NORGES BANK (867K shares), and STATE STREET CORP (851K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.